RECRUITING

Quantitative Neuromuscular Monitoring and Gastric Bypass Surgery

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a single site, prospective, non-blinded, non-randomized, before/after study. This study is designed to evaluate the impact of monitoring and reversal guidelines for neuromuscular blocking drugs on the post-operative outcomes for patients undergoing laparoscopic gastric bypass surgery.

Official Title

A Before/After Study of the Impact of Quantitative Neuromuscular Monitoring and Sugammadex Reversal Following Gastric Bypass Surgery

Quick Facts

Study Start:2023-02-08
Study Completion:2025-07
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05886218

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Not specified
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * age greater than 18 years
  2. * scheduled for an elective laparoscopic gastric bypass procedure
  1. * age less than 18 years
  2. * pregnancy
  3. * prisoners
  4. * significant co-existing lung disease including asthma or chronic obstructive pulmonary disease (COPD) requiring regular medication
  5. * patients who require supplemental oxygen pre-operatively to maintain a hemoglobin saturation (SpO2\>98%)

Contacts and Locations

Study Contact

Ana P Arias, BS
CONTACT
916-703-5456
apaarias@ucdavis.edu
Julio J Arana Pineda, BA
CONTACT
916-734-4074
jjaranapineda@ucdavis.edu

Study Locations (Sites)

UC Davis Medical Center
Sacramento, California, 95817
United States

Collaborators and Investigators

Sponsor: University of California, Davis

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-02-08
Study Completion Date2025-07

Study Record Updates

Study Start Date2023-02-08
Study Completion Date2025-07

Terms related to this study

Additional Relevant MeSH Terms

  • Sugammadex